NPR News: 05-02-2026 6PM EDT

The makers of the abortion pill mifepristone have directly petitioned the U.S. Supreme Court to keep the drug available through telemedicine, after a federal appeals court in Louisiana ruled yesterday that it must be prescribed in person. This marks the first major legal test of abortion access by telemedicine since Roe v. Wade was overturned, and the outcome could affect patients nationwide—including in states that protect abortion rights.

Telemedicine abortion pill access heads to the Supreme Court

The case centers on a rule that allowed patients to be prescribed mifepristone via telemedicine without an in-person visit. Louisiana argued that remote access undermined its abortion ban, and the Fifth Circuit Court of Appeals agreed, issuing a ruling that immediately reinstated the in-person requirement. The decision affects people across the country, not just in states with restrictive laws. The Reproductive Freedom Alliance, a coalition of 23 governors, said in a statement that they are "taking immediate action to protect patients and providers in our states" and will pursue "every legislative, executive, and legal avenue available."

Spirit Airlines ceases operations